Airway administration of tissue factor pathway inhibitor in...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/57 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2612646

The present invention provides methods for the local treatment of acute and chronic extravascular pulmonary fibrin deposition and/or reducing unwanted effects associated with systemic administration of natural anticoagulants to a subject via airway administration to the subject by intratracheal, intrabronchial or intraalveolar routes of natural anticoagulants or biologically active derivatives thereof.

L'invention concerne des méthodes de traitement local du dépôt de fibrine, aigu et chronique, dans l'espace pulmonaire extravasculaire et/ou de réduction des effets indésirables associés à l'administration par voie générale d'anticoagulants naturels, qui consistent à administrer à un sujet des anticoagulants ou des dérivés biologiquement actifs de ceux-ci par voie aérienne (intratrachéale, intrabronchiale ou intra-alvéolaire).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Airway administration of tissue factor pathway inhibitor in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Airway administration of tissue factor pathway inhibitor in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Airway administration of tissue factor pathway inhibitor in... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1884157

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.